BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28299879)

  • 1. How accurate are medical oncologists' impressions of management of metastatic colorectal cancer in Australia?
    Au L; Turner N; Wong HL; Field K; Lee B; Boadle D; Cooray P; Karikios D; Kosmider S; Lipton L; Nott L; Parente P; Tie J; Tran B; Wong R; Yip D; Shapiro J; Gibbs P
    Asia Pac J Clin Oncol; 2018 Apr; 14(2):e167-e174. PubMed ID: 28299879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel quality indicators for metastatic colorectal cancer management identify significant variations in these measures across treatment centers in Australia.
    Turner NH; Wong HL; Field K; Wong R; Shapiro J; Yip D; Nott L; Tie J; Kosmider S; Tran B; Desai J; McKendrick J; Zimet A; Richardson G; Iddawela M; Gibbs P
    Asia Pac J Clin Oncol; 2015 Sep; 11(3):262-71. PubMed ID: 25871458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab.
    Roohullah A; Wong HL; Sjoquist KM; Gibbs P; Field K; Tran B; Shapiro J; Mckendrick J; Yip D; Nott L; Gebski V; Ng W; Chua W; Price T; Tebbutt N; Chantrill L
    World J Gastroenterol; 2015 May; 21(17):5352-8. PubMed ID: 25954110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inventory of oncologists' unmet needs for tools to support decision-making about palliative treatment for metastatic colorectal cancer.
    Engelhardt EG; Révész D; Tamminga HJ; Punt CJA; Koopman M; Onwuteaka-Philipsen BD; Steyerberg EW; de Vet HCW; Coupé VMH
    BMC Med Inform Decis Mak; 2018 Dec; 18(1):132. PubMed ID: 30551735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of care and outcomes for elderly patients with metastatic colorectal cancer in Australia.
    Parakh S; Wong HL; Rai R; Ali S; Field K; Shapiro J; Wong R; Nott L; Gibbs P; Yip D
    J Geriatr Oncol; 2015 Sep; 6(5):387-94. PubMed ID: 26190441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Panitumumab use in metastatic colorectal cancer and patterns of RAS testing: results from a Europe-wide physician survey and medical records review.
    Han van Krieken J; Kafatos G; Bennett J; Mineur L; Tomášek J; Rouleau E; Fabian P; De Maglio G; García-Alfonso P; Aprile G; Parkar P; Downey G; Demonty G; Trojan J
    BMC Cancer; 2017 Nov; 17(1):798. PubMed ID: 29183279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing a national database for metastatic colorectal cancer management: perspectives and challenges.
    Field K; Wong HL; Shapiro J; Kosmider S; Tie J; Bae S; Yip D; McKendrick J; Nott L; Desai J; Harold M; Lipton L; Stefanou G; Lim L; Parente P; Gibbs P
    Intern Med J; 2013 Nov; 43(11):1224-31. PubMed ID: 23834128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the evolution in RAS mutation analysis in Australian patients with metastatic colorectal cancer.
    Chong CY; Jalali A; Wong HL; Loft M; Wong R; Lee M; Gately L; Hong W; Shapiro J; Kosmider S; Tie J; Ananda S; Yeung JM; Ma B; Burge M; Jennens R; Tran B; Lee B; Lim L; Dean A; Nott L; Gibbs P
    Asia Pac J Clin Oncol; 2022 Oct; 18(5):e363-e368. PubMed ID: 35073441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparable survival outcome of metastatic colorectal cancer in Indigenous and non-Indigenous patients: Retrospective analysis of the South Australian metastatic colorectal cancer registry.
    Tomita Y; Karapetis CS; Roder D; Beeke C; Hocking C; Roy AC; Townsend AR; Padbury R; Maddern G; Price TJ
    Aust J Rural Health; 2016 Apr; 24(2):85-91. PubMed ID: 26255652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation oncologists' scope of practice and role in cancer management in Australia, New Zealand, and Singapore: Are we clinicians or technicians?
    Leung J; James M; Adams G; Gupta N
    J Med Imaging Radiat Oncol; 2023 Oct; 67(7):769-776. PubMed ID: 37469112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consideration of Metastasis-Directed Therapy for Patients With Metastatic Colorectal Cancer: Expert Survey and Systematic Review.
    Miller ED; Klamer BG; Cloyd JM; Pawlik TM; Williams TM; Hitchcock KE; Romesser PB; Mamon HJ; Ng K; Gholami S; Chang GJ; Anker CJ
    Clin Colorectal Cancer; 2024 Jun; 23(2):160-173. PubMed ID: 38365567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in Advanced Gastric Cancer.
    Vasista A; Stockler M; Martin A; Pavlakis N; Sjoquist K; Goldstein D; Gill S; Jain V; Liu G; Kannourakis G; Kim YH; Nott L; Snow S; Burge M; Harris D; Jonker D; Chua YJ; Epstein R; Bonaventura A; Kiely B
    Oncologist; 2019 Nov; 24(11):e1102-e1107. PubMed ID: 30936377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and outcomes of metastatic colorectal cancer in Australia: defining differences between public and private practice.
    Field K; Shapiro J; Wong HL; Tacey M; Nott L; Tran B; Turner N; Ananda S; Richardson G; Jennens R; Wong R; Power J; Burge M; Gibbs P
    Intern Med J; 2015 Mar; 45(3):267-74. PubMed ID: 25403925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating survival in advanced cancer: a comparison of estimates made by oncologists and patients.
    Smith-Uffen MES; Johnson SB; Martin AJ; Tattersall MHN; Stockler MR; Bell ML; Detering K; Clayton JM; Silvester W; Clarke S; Vaccaro L; Beale P; Kiely BE
    Support Care Cancer; 2020 Jul; 28(7):3399-3407. PubMed ID: 31781946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic colorectal cancer treatment patterns according to kirsten rat sarcoma viral oncogene homolog genotype in U.S. Community-based oncology practices.
    Landsman-Blumberg PB; Carter GC; Johnson BH; Sedgley R; Nicol SJ; Li L; Shankaran V
    Clin Colorectal Cancer; 2014 Sep; 13(3):178-84. PubMed ID: 25065655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceptions of cancer of unknown primary site: a national survey of Australian medical oncologists.
    Karapetis CS; Guccione L; Tattersall MH; Gooden H; Vajdic CM; Lambert S; Robotin M; Mileshkin L; Schofield P
    Intern Med J; 2017 Apr; 47(4):408-414. PubMed ID: 28101916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival improvements associated with access to biological agents: Results from the South Australian (SA) metastatic colorectal cancer (mCRC) registry.
    Tomita Y; Karapetis CS; Ullah S; Townsend AR; Roder D; Beeke C; Roy AC; Padbury R; Price TJ
    Acta Oncol; 2016; 55(4):480-5. PubMed ID: 26878155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 'real-life' impact of adding bevacizumab to first-line therapy in metastatic colorectal cancer patients: a large Israeli retrospective cohort study.
    Hammerman A; Greenberg-Dotan S; Battat E; Feldhamer I; Bitterman H; Brenner B
    Acta Oncol; 2015 Feb; 54(2):164-70. PubMed ID: 25350524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical Oncologists' Experiences in Using Genomic Testing for Lung and Colorectal Cancer Care.
    Gray SW; Kim B; Sholl L; Cronin A; Parikh AR; Klabunde CN; Kahn KL; Haggstrom DA; Keating NL
    J Oncol Pract; 2017 Mar; 13(3):e185-e196. PubMed ID: 28095174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Australian contemporary management of synchronous metastatic colorectal cancer.
    Malouf P; Gibbs P; Shapiro J; Sockler J; Bell S
    ANZ J Surg; 2018 Jan; 88(1-2):71-76. PubMed ID: 27122066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.